
|Videos|October 8, 2021
New Data Surrounding Pediatric Pneumococcal Disease Shows Promise
Musey discussed the highlights of the new data and how these 2 studies are different than previous studies in this topic area.
Advertisement
Pharmacy Times spoke with Luwy Musey, executive director in biologics and vaccines clinical research at Merck, about the results from two phase 3 pediatric studies surrounding pneumococcal disease that was presented at the IDWeek 2021 conference.
Musey discussed the highlights of the new data and how these 2 studies are different than previous studies in this topic area.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
AHA/ACC CKM Guideline Formally Endorses GLP-1 Therapies for Kidney, Heart Protection
2
GLP-1s and Muscle Loss: The Conversation Pharmacists Are Not Having, But Should Be
3
McKesson ideaShare 2026: Building Specialty and Infusion Capacity From the Ground Up
4
Ammoxetine: Emerging Data from a Phase 2 Antidepressant Trial
5





















































































































